1315 Capital overview
Stories about 1315 Capital
1315 Capital acquires Argonaut's life sciences and diagnostics unit
The divested unit, now operating independently as Aluris Sciences, provides contract manufacturing for life sciences, diagnostics and combination drug product customers from formulation through commercial production.
Pharma packaging and storage services attract PE: Five deals
1315 Capital, Aurora Capital and Platinum Equity are among the PE firms investing in the pharma packaging and storage services sector.
1315 collects $500m across two funds
Fund III beat its $350 million target while EGB exceeded its $150 million target.
Emerging firm 1315 Capital scores pledge from LA City for its third fund
LA City’s commitment is an example of a public pension system finding opportunities with newer funds and emerging managers despite the general preference of public system LPs to stick with established managers.
1315 Capital raises $300 mln for second fund
Philadelphia-based 1315 Capital has raised $300 million for its fund, 1315 Capital II, according to a regulatory filing https://www.sec.gov/Archives/edgar/data/1730825/000173082518000001/xslFormDX01/primary_doc.xml The firm invests in pharmaceutical, medical technology, and healthcare service companies, according to its website http://www.1315capital.com/ It is led by Adele Oliva, Michael Koby, and Brian Schwenk. The fund closed at its hard cap of $300 million, exceeding its $250 million target, according to a press release https://www.prnewswire.com/news-releases/1315-capital-completes-single-close-on-over-300-million-healthcare-growth-equity-fund-300596659.html The filing lists 57 investors.
1315 Capital raises $300m
The US-based expansion and growth equity firm closes second fund at hard-cap.
Reber joins 1315 Capital as partner
Philadelphia-based 1315 Capital, a healthcare-focused growth equity firm, has hired Matthew Q. Reber as a partner. Previously, Reber worked at HealthCare Royalty Partners where he most recently served as a managing director.
1315 Capital contact information
Offices
2929 Walnut Street, Suite 1240, Philadelphia, 19104, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
 Mr. Brian Schwenk | Job titleChief Financial Officer and Chief Compliance Officer | LocationPhiladelphia, United States | Email  ----------- |
| Mr. Ian B. Li | Job titlePrincipal, Investments | LocationPhiladelphia, United States | Email -------- |
| Ms. Jordan Brown | Job titlePrincipal, Investments | LocationPhiladelphia, United States | Email ---------- |
| Mr. Edward Chan | Job titlePartner | LocationPhiladelphia, United States | Email ----------- |
1315 Capital funds managed
Funds in market: 2
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size --------- | Open date- | Strategy ----- | |
Fund size -------- | Open date- | Strategy ----- | |
Closed funds: 4
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ------- | Close dateOct 2023 | Strategy ----- | |
Fund size ----- | Close dateJun 2023 | Strategy ---------- | |
Fund size ---------- | Close dateJun 2016 | Strategy ----------- | |
Stories that mention 1315 Capital
Here are the 9 VCs in MassPRIM's diverse-manager portfolio
Of the $424m MassPRIM committed to diverse managers last year, $158m went to four managers of venture capital and/or growth funds.
MassPRIM dedicated over $400m to diverse-owned PE managers in 2022
Many LPs are focusing on re-ups with existing relationships due to the current economic landscape. LPs with dedicated programs may serve as a valuable lifeline for emerging and diverse-owned managers.
Onkos Surgical reels in $15m Series C
Onkos Surgical, a provider of solutions for musculoskeletal oncology and complex orthopaedic procedures, has raised $15 million in Series C funding.
Encore Dermatology secures $20 mln from Horizon
Horizon has provided a $20 million venture loan facility to Encore Dermatology. Headquartered in Malvern, Pennsylvania, Encore Dermatology is a specialty dermatology company. Encore is backed by EW Healthcare Partners, 1315 Capital and Longitude Capital.
Onkos Surgical lands $17.6 mln Series B
Parsippany, New Jersey-based Onkos Surgical Inc, a specialty medtech company focused on surgical oncology, has raised $17.6 million in Series B funding. Canaan Partners led the round with participation from return backers 1315 Capital and 3D Systems.